Fig. 2: Results from targeted amplicon sequencing in 162 patients with CBFB/MYH11-rearrangement (left), and 130 patients with RUNX1/RUNX1T1-rearrangement (right).
Each column represents one patient, each line shows the status of the indicated genetic aberrations.
